Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Regulatory

    Class III Device

    In one line
    FDA's highest-risk device class, generally requiring PMA.
    Definition
    Class III devices are those that support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential, unreasonable risk of illness or injury. They generally require PMA. Some older preamendments device types were historically cleared through 510(k) until FDA called for PMAs. In the EU, Class III is also the highest risk class under the MDR, requiring notified body review of the technical documentation and, for some implantables, a clinical evaluation consultation procedure.
    Why it matters
    Examples include implantable defibrillators and life-supporting devices. Class III devices undergo the most stringent regulatory review.
    Common pitfalls
    • •A common pitfall is misinterpreting the criteria for Class III, assuming only "life-sustaining" devices qualify, missing those preventing impairment or posing unreasonable risk.
    • •Another mistake is underestimating the time and resources required for a Class III PMA submission, leading to significant project delays.
    • •Failing to adequately address clinical evidence requirements for Class III devices is a frequent pitfall, as these devices demand robust safety and effectiveness data.
    • •Thinking a device is Class II solely because it is not implantable or life-supporting can be a pitfall, as other risk factors can elevate classification.
    • •Incorrectly applying predicates for substantial equivalence to Class III devices, where PMA is typically required, is a common error.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.